Assembly Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASMB and other ETFs, options, and stocks.About ASMB
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate.
CEOJason A. Okazaki
CEOJason A. Okazaki
Employees73
Employees73
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2005
Founded2005
Employees73
Employees73
ASMB Key Statistics
Market cap562.30M
Market cap562.30M
Price-Earnings ratio-7.29
Price-Earnings ratio-7.29
Dividend yield—
Dividend yield—
Average volume81.61K
Average volume81.61K
High today$35.98
High today$35.98
Low today$34.42
Low today$34.42
Open price$35.64
Open price$35.64
Volume190.48K
Volume190.48K
52 Week high$39.71
52 Week high$39.71
52 Week low$7.75
52 Week low$7.75
Stock Snapshot
With a market cap of 562.3M, Assembly Biosciences(ASMB) trades at $35.38. The stock has a price-to-earnings ratio of -7.29.
On 2025-12-08, Assembly Biosciences(ASMB) stock moved within a range of $34.42 to $35.98. With shares now at $35.38, the stock is trading +2.8% above its intraday low and -1.7% below the session's peak.
Trading activity shows a volume of 190.48K, compared to an average daily volume of 81.61K.
The stock's 52-week range extends from a low of $7.75 to a high of $39.71.
The stock's 52-week range extends from a low of $7.75 to a high of $39.71.
People also own
Based on the portfolios of people who own ASMB. This list is generated using Robinhood data, and it’s not a recommendation.